85 related articles for article (PubMed ID: 31850667)
1. From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage.
Nigi L; Maccora C; Dotta F; Sebastiani G
Diabetes Metab Res Rev; 2020 May; 36(4):e3264. PubMed ID: 31850667
[TBL] [Abstract][Full Text] [Related]
2. Organ donor specimens: What can they tell us about type 1 diabetes?
Campbell-Thompson M
Pediatr Diabetes; 2015 Aug; 16(5):320-30. PubMed ID: 25998576
[TBL] [Abstract][Full Text] [Related]
3. The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas.
Atkinson MA; Mirmira RG
Cell Metab; 2023 Sep; 35(9):1500-1518. PubMed ID: 37478842
[TBL] [Abstract][Full Text] [Related]
4. Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.
Bruggeman BS; Campbell-Thompson M; Filipp SL; Gurka MJ; Atkinson MA; Schatz DA; Jacobsen LM
Front Endocrinol (Lausanne); 2021; 12():778912. PubMed ID: 34912300
[TBL] [Abstract][Full Text] [Related]
5. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes.
Campbell-Thompson M; Wasserfall C; Kaddis J; Albanese-O'Neill A; Staeva T; Nierras C; Moraski J; Rowe P; Gianani R; Eisenbarth G; Crawford J; Schatz D; Pugliese A; Atkinson M
Diabetes Metab Res Rev; 2012 Oct; 28(7):608-17. PubMed ID: 22585677
[TBL] [Abstract][Full Text] [Related]
6. A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry.
Damond N; Engler S; Zanotelli VRT; Schapiro D; Wasserfall CH; Kusmartseva I; Nick HS; Thorel F; Herrera PL; Atkinson MA; Bodenmiller B
Cell Metab; 2019 Mar; 29(3):755-768.e5. PubMed ID: 30713109
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes.
Poudel A; Savari O; Striegel DA; Periwal V; Taxy J; Millis JM; Witkowski P; Atkinson MA; Hara M
Endocrine; 2015 Aug; 49(3):693-702. PubMed ID: 25605478
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound with sub-micron sized contrast agents detects insulitis in mouse models of type1 diabetes.
Ramirez DG; Abenojar E; Hernandez C; Lorberbaum DS; Papazian LA; Passman S; Pham V; Exner AA; Benninger RKP
Nat Commun; 2020 May; 11(1):2238. PubMed ID: 32382089
[TBL] [Abstract][Full Text] [Related]
9. Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made.
Morgan NG; Richardson SJ
Diabetologia; 2018 Dec; 61(12):2499-2506. PubMed ID: 30255378
[TBL] [Abstract][Full Text] [Related]
10. Imaging in Type 1 Diabetes, Current Perspectives and Directions.
Tinklepaugh J; Mamrak NE
Mol Imaging Biol; 2023 Dec; 25(6):1142-1149. PubMed ID: 37934378
[TBL] [Abstract][Full Text] [Related]
11. Type 1 diabetes in the pancreas: A histological perspective.
Leete P
Diabet Med; 2023 Dec; 40(12):e15228. PubMed ID: 37735524
[TBL] [Abstract][Full Text] [Related]
12. Integrating multi-omics data to analyze the potential pathogenic mechanism of CTSH gene involved in type 1 diabetes in the exocrine pancreas.
Song Z; Li S; Shang Z; Lv W; Cheng X; Meng X; Chen R; Zhang S; Zhang R
Brief Funct Genomics; 2023 Dec; ():. PubMed ID: 38050341
[TBL] [Abstract][Full Text] [Related]
13. Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program.
Shapira SN; Naji A; Atkinson MA; Powers AC; Kaestner KH
Cell Metab; 2022 Dec; 34(12):1906-1913. PubMed ID: 36206763
[TBL] [Abstract][Full Text] [Related]
14. Editorial: The contribution of viruses and innate immune system in the pathogenesis of type 1 diabetes.
Nigi L; Laiho JE; Hyöty H; Dotta F
Front Endocrinol (Lausanne); 2023; 14():1335716. PubMed ID: 38161972
[No Abstract] [Full Text] [Related]
15. Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors.
Nigi L; Brusco N; Grieco GE; Fignani D; Licata G; Formichi C; Aiello E; Marselli L; Marchetti P; Krogvold L; Jorgensen KD; Sebastiani G; Dotta F
Front Immunol; 2022; 13():833141. PubMed ID: 35359976
[TBL] [Abstract][Full Text] [Related]
16. Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes.
Gomez-Muñoz L; Perna-Barrull D; Caroz-Armayones JM; Murillo M; Rodriguez-Fernandez S; Valls A; Vazquez F; Perez J; Corripio R; Castaño L; Bel J; Vives-Pi M
Front Immunol; 2022; 13():825426. PubMed ID: 35280980
[TBL] [Abstract][Full Text] [Related]
17. Type I IFN-Driven Immune Cell Dysregulation in Rat Autoimmune Diabetes.
Qaisar N; Arowosegbe A; Derr AG; Kucukural A; Satish B; Racicot R; Guo Z; Trombly MI; Wang JP
Immunohorizons; 2021 Oct; 5(10):855-869. PubMed ID: 34702762
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools.
Grieco GE; Fignani D; Formichi C; Nigi L; Licata G; Maccora C; Brusco N; Sebastiani G; Dotta F
Front Immunol; 2021; 12():682948. PubMed ID: 34177928
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes mellitus: much progress, many opportunities.
Powers AC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33759815
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic
Fignani D; Licata G; Brusco N; Nigi L; Grieco GE; Marselli L; Overbergh L; Gysemans C; Colli ML; Marchetti P; Mathieu C; Eizirik DL; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():596898. PubMed ID: 33281748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
